Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update

Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in the heart, peripheral nerves, and other tissues and organs.

Saved in:
Bibliographic Details
Main Authors: Dispenzieri, Angela (Author) , Coelho, Teresa (Author) , Conceição, Isabel (Author) , Waddington-Cruz, Márcia (Author) , Wixner, Jonas (Author) , Kristen, Arnt (Author) , Rapezzi, Claudio (Author) , Planté-Bordeneuve, Violaine (Author) , Gonzalez-Moreno, Juan (Author) , Maurer, Mathew S. (Author) , Grogan, Martha (Author) , Chapman, Doug (Author) , Amass, Leslie (Author)
Format: Article (Journal)
Language:English
Published: 18 June 2022
In: Orphanet journal of rare diseases
Year: 2022, Volume: 17, Pages: 1-12
ISSN:1750-1172
DOI:10.1186/s13023-022-02359-w
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13023-022-02359-w
Get full text
Author Notes:Angela Dispenzieri, Teresa Coelho, Isabel Conceição, Márcia Waddington-Cruz, Jonas Wixner, Arnt V. Kristen, Claudio Rapezzi, Violaine Planté-Bordeneuve, Juan Gonzalez-Moreno, Mathew S. Maurer, Martha Grogan, Doug Chapman and Leslie Amass on behalf of the THAOS investigators
Description
Summary:Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in the heart, peripheral nerves, and other tissues and organs.
Item Description:Gesehen am 29.08.2022
Physical Description:Online Resource
ISSN:1750-1172
DOI:10.1186/s13023-022-02359-w